Core Concepts In EP for the Allied Professional is designed to serve Allied Professionals (APs) in the EP community. It is intended to be an indispensable tool for providing fundamentally sound EP knowledge for APs.
This course will have over 20 recorded didactic lectures delivered by leading experts covering:
• Bradyarrhythmias
• CIEDS
• General Concepts
• Tachyarrhythmias
• Special Topics
Akash R. Patel, MD, FHRS, CEPS-P
UCSF Benioff Children`s Hospital | Pediatric and Congenital Electrophysiologist
Alessio Gasperetti, MD
Johns Hopkins University | Postdoc/Advanced Degree Student
Amayrah Yaeger, BSN, RN
Hospital of the University of Pennsylvania | Remote Monitoring Clinic Coordinator
Andrew D. Beaser, MD
University of Chicago | Electrophysiologist
Artur Fedorowski, MD, PhD
Karolinska University Hospital, Stockholm, Sweden | Associate Professor
Brian Long, BS, BSN, MBA
Emory University Healthcare | Clinical Staff Nurse
Brian Olshansky, MD, FHRS, CCDS
Mercy Hospital - North Iowa | Electrophysiologist
Brynn E. Dechert-Crooks, APN, FHRS, CCDS
C.S. Mott Children’s Hospital | Nurse Practitioner
David Bradley, MD, FHRS, CEPS-P
Univerity of Michigan - Mott Children`s Hospital | Director of Electrophysiology
David Lin, MD, FHRS
University of Pennsylvania | Associate Professor of Medicine
Edward Walsh, MD, FHRS, CCDS, CEPS-P
Boston Children`s Hospital | Associate Chief of Cardiology for Clinical Affairs
Edward P. Gerstenfeld, MD, FHRS
University of California, San Francisco I Professor
Elizabeth S. Kaufman, MD, FHRS
MetroHealth Medical Centre | Professor of Medicine
Emilie Sauser, APN, FNP
University of Chicago Medical Center | Nurse Practitioner
Erin Flatley, BSN, MSN, NP
University of California San Francisco | Nurse Practitioner
Frederic Sacher, MD, PhD
LIRYC Institute/ Bordeaux University | Cardiologist
Heather M. MacLeod, MS
SDY Case Registry | Genetic Counselor
Jackson Liang, DO
University of Michigan | Assistant Professor
Jennifer Sobacki, PAC
University of Chicago | Physician Assistant Specialist
Jeremy P. Moore, MD, MS, FHRS, CCDS, CEPS-P
UCLA Medical Center | Physician
Jonathan Walter Dukes, MD
Community Memorial Hospital | Physician
Jorge Romero, MD, FHRS
Brigham and Women’s Hospital - Harvard Medical School | Director
Lauren Ashley Rousseau, PAC, CCDS
Brigham and Women’s Hospital - Harvard Medical School | Physician Assistant
Laurie Racenet, MSN, FNP, FHRS, CEPS, CCDS
Alaska Heart and Vascular Institute | Nurse Practitioner
L. Lee Eckhardt, MD, FHRS
University of Wisconsin, School of Medicine | Associate Professor of Medicine
Linda K. Ottobani, PhD, CNS, FHRS, CCDS
Stanford Healthcare | Clinical Nurse Specialist
Marina Cerrone, MD
NYU School of Medicine | Assistant Professor
Martin Maron, MD
Tufts - New England Medical Center | Assistant Professor of Medicine
Matthew W. Martinez, MD
Mayo Clinic College of Medicine | Physician
Melissa R. Brown, PAC, FHRS, CCDS
Emory Cardiology | Physician Assistant
Melissa Olen, MSN
Nicklaus Children`s Hospital | Electrophysiology Nurse Pracitioner
Melissa Robinson, MD, FHRS, CCDS
University of Washington | Clinical Associate Professor
Melvin Scheinman, MD, FHRS
University of California - San Francisco | Professor of Medicine
Michael John Ackerman, MD, PhD
Mayo Clinic – Rochester | Genetic Cardiologist
Michele Brignole, MD
Ospedali del Tigullio | Physician
Miguel A. Leal, MD, FHRS
University of Wisconsin | Physician
Mitchell I. Cohen, MD, FHRS, CCDS, CEPS-P
Inova Children’s Hospital | Co-Director Inova Children's Heart Center
Nicole Haupert, NP
UCSF Benioff Children's Hospital | Pediatric Electrophysiology Nurse Practitioner
Patricia L Arscott, MS, CGC
University of Michigan | Genetic Counselor
Peter J. Schwartz, MD
Istituto Auxologico Italiano IRCCS | Professor of Cardiology
Philippe Maury, MD
Hopital Rangueil Toulouse | Doctor of Medicine
Rakesh Gopinathannair, MA, MD, FHRS
Kansas City Heart Rhythm Institute | Director of Cardiac Electrophysiology
Raul Weiss, MD, FHRS
Ohio State University | Physician
Reginald T. Ho, MD, FHRS
Thomas Jefferson University Hospital | Physician
Richard Sutton, DSC, MBBS, FHRS
Imperial College | Professor
Robert Hipp, MBA, MS, PA
University of Pennsylvania | Physician Assistant
Robert D. Schaller, DO, FHRS
University of Pennsylvania | Cardiac Electrophysiologist
Ryan Cunnane, MD
Scott Cox, PAC
Main Line Health System | Physician Assistant
Sharon M. Holloway, ACNP
University of Chicago Hospital | Nurse Practitioner
Shelley Zieroth, MD
SBH Heart Failure and Transplant Clinics | Cardiologist
Steve Ommen, MD
Susan Turpin, MS, CPNP-AC, CNS, CCDS
UCSF Benioff Children’s Hospital | Pediatric Nurse Practitioner
T. Jennifer Walker, MSN, ANP
University of North Carolina | Nurse Practitioner
Tara Parham, DNP
University of Pennsylvania | Nurse Practitioner
Wendy S. Tzou, MD, FHRS
University of Colorado Denver | Electrophysiologist
Win-Kuang Shen, MD, FHRS
Mayo Clinic College of Medicine, Mayo Clinic Arizona | Professor of Medicine
Zaid Aziz, MD
University of Chicago | Assistant Professor
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.
Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.
ACCME Definition:
*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Examples of such organizations include:
All relevant financial relationships have been mitigated.Planners:P. Aziz: No relevant financial relationships with ineligible companies to disclose.S. Cox: Honoraria/Speaking/Consulting Fee: ScottCare, Inc.E. Daoud: Fellowship Support: Biotronik, Medtronic, Biosense Webster, Inc., Boston Scientific, Abbott. Research (Contracted Grants for PIs and Named Investigators Only): Abbott, Biosense Webster, Inc. Ownership/Partnership/Principal: S4 MedicalC. DeSimone: No relevant financial relationships with ineligible companies to disclose.M. Lloyd: Honoraria/Speaking/Consulting Fee: Boston Scientific, MedtronicR. Mullins: No relevant financial relationships with ineligible companies to disclose.H. Nayak: Honoraria/Speaking/Consulting Fee: Pfizer, Inc., Bristol-Myers Squibb, Boston Scientific, Abbott, Spectranetics Corporation, Aziyo Biologics, Sanofi. Research (Contracted Grants for PIs and Named Investigators Only): PhilipsL.K. Racenet: No relevant financial relationships with ineligible companies to disclose.J. Schaeffer: Honoraria/Speaking/Consulting Fee: CHART Healthcare AcademyT. Trela: No relevant financial relationships with ineligible companies to disclose.E. Zado: No relevant financial relationships with ineligible companies to disclose.Faculty:M. J. Ackerman: Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Daiichi Sankyo, UpToDate, ARMGO Pharma, LQT Therapeutics, Abbott, Bristol-Myers Squibb. Research (Contracted Grants for PIs and Named Investigators Only): LQT Therapeutics. Intellectual Property Rights: AliveCor, Anumana, Pfizer, Inc.P. L. Arscott: Speakers' Bureau: Ambry GeneticsZ. Aziz: Honoraria/Speaking/Consulting Fee: BiotronikA. D. Beaser: No relevant financial relationships with ineligible companies to disclose.D. Bradley: No relevant financial relationships with ineligible companies to disclose.M. Brignole: No relevant financial relationships with ineligible companies to disclose.M. I. Cohen: No relevant financial relationships with ineligible companies to disclose.S. Cox: Honoraria/Speaking/Consulting Fee: ScottCare, Inc.B.E. Dechert-Crooks: No relevant financial relationships with ineligible companies to disclose.J. W. Dukes: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Medtronic, Biotronik, BMS/Pfizer AllianceL. L. Eckhardt: Honoraria/Speaking/Consulting Fee: UpToDateA. Federowski: Honoraria/Speaking/Consulting Fee: Biotronik, MedtronicE. Flatley: No relevant financial relationships with ineligible companies to disclose.A. Gasparetti: No relevant financial relationships with ineligible companies to disclose.E. Gerstenfeld: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Medtronic, Abbott, Boston Scientific. Research (Contracted Grants for PIs and Named Investigators Only): Biosense Webster, Inc., FarapulseR. Gopinathannair: Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster, Inc., Boston Scientific, Zoll Medical Corporation, Sanofi, Pfizer, Inc., Biotronik, Academy for Continued Healthcare LearningR. Hipp: Honoraria/Speaking/Consulting Fee: BioTel, Medtronic, Inc.R. Ho: Honoraria/Speaking/Consulting Fee: Abbott, Boston ScientificE. S. Kaufman: No relevant financial relationships with ineligible companies to disclose.M. Leal: No relevant financial relationships with ineligible companies to disclose.J. Liang: Honoraria/Speaking/Consulting Fee: Biotronik AbbottD. Lin: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., BioTelemetryH. MacLeod: No relevant financial relationships with ineligible companies to disclose.M. Maron: Honoraria/Speaking/Consulting Fee: Cytokinetics. Research (Contracted Grants for PIs and Named Investigators Only): iRhythm Technologies, Celltrion, Takeda, ImbriaC. Miyake: No relevant financial relationships with ineligible companies to disclose.J. P. Moore: No relevant financial relationships with ineligible companies to disclose.M. Olen: No relevant financial relationships with ineligible companies to disclose.B. Olshansky: Honoraria/Speaking/Consulting Fee: Boehringer Ingelheim, Amarin, LundbeckL. Ottobani: No relevant financial relationships with ineligible companies to disclose.A. R. Patel: No relevant financial relationships with ineligible companies to disclose.T. Parham: No relevant financial relationships with ineligible companies to disclose.L. K. Racenet: No relevant financial relationships with ineligible companies to disclose.M. Robinson: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Biotronik, Abbott, Medtronic, Inc., Boston Scientific. Research (Contracted Grants for PIs and Named Investigators Only): Abbott, MedtronicJ. Romero: Honoraria/Speaking/Consulting Fee: Sanofi. Research (Contracted Grants for PIs and Named Investigators Only): Biosense Webster, Inc. L.A. Rousseau: Honoraria/Speaking/Consulting Fee: MedtronicF. Sacher: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Boston Scientific, Medtronic, Abbott, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim, MicroPort, inHEARTE. Sauser: No relevant financial relationships with ineligible companies to disclose.R. D. Schaller: Honoraria/Speaking/Consulting Fee: Medtronic, AbbottM. Scheinman: Honoraria/Speaking/Consulting Fee: Abbott, Biosense Webster, Inc., BiotronikW. Shen: No relevant financial relationships with ineligible companies to disclose.P. J. Schwartz: Honoraria/Speaking/Consulting Fee: AmgenJ. Sobacki: No relevant financial relationships with ineligible companies to disclose.R. Sutton: Honoraria/Speaking/Consulting Fee: Medtronic. Speakers' Bureau: Abbott. Stocks - Publicly Traded: Boston Scientific, Edwards LifesciencesW. Tzou: Honoraria/Speaking/Consulting Fee: Medtronic, Biosense Webster, Inc., BioSig, Abbott, Boston Scientific, BiotronikT. J. Walker: No relevant financial relationships with ineligible companies to disclose.E. Walsh: No relevant financial relationships with ineligible companies to disclose.R. Weiss: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., Boston Scientific, Abbott, Impulse Dyanmics USA, Biotronik. Fellowship Support: Abbott, Medtronic, Biotronik, Biosense Webster, Inc., Boston ScientificA. Yaeger: No relevant financial relationships with ineligible companies to disclose.S. Zieroth: Honoraria/Speaking/Consulting Fee: Servier, Abbott, Akcea, AstraZeneca, Amgen, Alynylam Pharmaceuticals, MSD/Bayer Virtual Global Advisory Board Member, Boehringer Ingelheim, Eli LillyStaff (note: Staff are not directly responsible for the planning or the content of educational activities. Disclosures are provided as a matter of transparency only):S. Alfano: No relevant financial relationships with ineligible companies to disclose.M. Anderson: No relevant financial relationships with ineligible companies to disclose.J. Glenn: No relevant financial relationships with ineligible companies to disclose.P. Magnani: No relevant financial relationships with ineligible companies to disclose.K. Quille: Honoraria/Speaking/Consulting Fee: Pfizer, Inc. Salary from Employment: Biosense Webster, Inc.Content Reviewers:B. Afolabi: No relevant financial relationships with ineligible companies to disclose.M. R. Afzal: Honoraria/Speaking/Consulting Fee: Abbott MedicalD. Alexander: No relevant financial relationships with ineligible companies to disclose.M. Berger: No relevant financial relationships with ineligible companies to disclose.S. Brancato: No relevant financial relationships with ineligible companies to disclose.J. Chyou: Honoraria/Speaking/Consulting Fee: Medtronic, Inc.T. Crawford: No relevant financial relationships with ineligible companies to disclose.F. Del Carpio Munoz: No relevant financial relationships with ineligible companies to disclose.R. Dendi: No relevant financial relationships with ineligible companies to disclose.A. Elsharkawi: No relevant financial relationships with ineligible companies to disclose.A. Elvan: Research (Contracted Grants for PIs and Named Investigators Only): Medtronic, Boston Scientific, AbbottJ. Gabriels: No relevant financial relationships with ineligible companies to disclose.S. Gautam: No relevant financial relationships with ineligible companies to disclose.A. Hussein: No relevant financial relationships with ineligible companies to disclose.M. Infeld: Honoraria/Speaking/ConsultingFee: Biosense Webster, Inc.L. Jackson, II: Honoraria/Speaking/Consulting Fee: Medtronic, Biosense Webster, Inc., Medscape, Zoll Medical Corporation, Johnson and JohnsonS. Karim: No relevant financial relationships with ineligible companies to disclose.P. Karpawich: No relevant financial relationships with ineligible companies to disclose.H. Kawata: Honoraria/Speaking/Consulting Fee: BiotronikI. Koniari: No relevant financial relationships with ineligible companies to disclose.P. LeLorier: Honoraria/Speaking/Consulting Fee: Medtronic; Fellowship Support: Biotronik, AbbottD. Lin: Honoraria/Speaking/Consulting Fee: Biosense Webster, Inc., BioTelemetry, Abbott MedicalS. Majumdar: No relevant financial relationships with ineligible companies to disclose.T. McGarry: No relevant financial relationships with ineligible companies to disclose.T. Moukabary: No relevant financial relationships with ineligible companies to disclose.S. Mountantonakis: Honoraria/Speaking/Consulting Fee: Medtronic, BiotronikM. Nageh: No relevant financial relationships with ineligible companies to disclose.B. Olshansky: Honoraria/Speaking/Consulting Fee: Lundbeck, Boehringer Ingelheim, AmarinR. Schreier: No relevant financial relationships with ineligible companies to disclose.K. Srivasthasn: Honoraria/Speaking/Consulting Fee: Abbott
The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company within the 24 months prior to the disclosure.
The Heart Rhythm Society takes steps to assure its learners and the public that the content of certified activities is accurate and reliable. The following principles are applied to the process of validating CME content. The content is peer-reviewed to ensure the following:Fair Balance - that content is balanced among various options available for treatment and not biased toward a particular product or manufacturer.
Patient Treatment Recommendations - that patient treatment recommendations contained in the content are evidence-based, are appropriate for the target audience, and that the patient treatment recommendations contribute to overall improvement in patient care.
Scientific Validity - those scientific studies cited in the activity conform to standards accepted by the scientific community.
Learning Objectives - that the educational content supports the learning objectives of the activity, and that the objectives stated for performance-in-practice are actionable and measurable.
Omissions - that no seminal studies, data, or best evidence are missing.